Fundraising FoxSofinnova Ventures — 2021 Investments
8 investments dated 2021 · listed companies and verified rows first · show all
Vera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant.
BiotechDigital HealthMedical DevicesSouth San Francisco, US
Marshall Fordyce(Executive Officer, Director)in
BoardBeth Seidenberg(Director)inKurt von Emster(Director)inPatrick Enright(Director)inAndrew Cheng(Director)
Board seatMaha Katabi· per SEC Form D
Co-investorsKleiner PerkinsLongitude CapitalAbingworthSofinnova Venture Partners
Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.
BiotechFemTechHealthtechMedical DevicesRedwood City, US
Karl Y. Hostetler(Executive Officer, Director)inGail Maderis(Director)inKristine Ball(President & CEO)inElaine Chien(Executive Officer)inSarah Walter(Executive Officer)inRaju Gadiraju(Executive Officer)in
Board seatDavid Kabakoff· per SEC Form D
Co-investorsAdjuvant CapitalAvestria VenturesBrace PharmaCanaan PartnersGaingelsGV (Google Ventures)+6 more
__Twitter.png)
ARS Pharmaceuticals is a biopharmaceutical company developing treatments for severe allergic reactions, with a focus on patient-friendly, easy-to-use intranasal therapies.
BiotechHealthtechMedical DevicesSan Diego, US
Richard Lowenthal(Executive Officer, Director)inPratik Shah(Director)
Board seatJonathan Leff· per SEC Form D · $55M raise · filed Sep 2021
Co-investorsNextech InvestOrbiMedRA CapitalSR One Capital Management
Novartis is a pharmaceutical company that develops and commercializes prescription medicines and therapies across therapeutic areas including oncology, cardiovascular disease, and immunology.
BiotechMedical Devices
Co-investorsCambridge Innovation Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bolt TherapeuticsGyroscope Therapeutics LtdAthena TherapeuticsCinCor Pharma
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.